医学论文英翻中

医学论文英翻中

本文回顾我们调查的化学成分的几种
植物确定甘草的根，这导致表征13时任葡糖苷酸—
皂苷命名licorice-saponins（一–升），apioglycyrrhizin，和araboglycyrrhizin，
与甘草酸和甘草酸18α和49种酚类化合物
及其苷（11时任）。

望采纳~~可追问。
祝您幸福！

心血管的英文论文以及翻译

Chronic kidney disease is a risk factor for cardiovascular disease

Chronic kidney disease (CKD) is a widespread concern of public health, the incidence increased gradually, at the same time brought about serious consequences and problems. We note that the patient's renal failure is dialysis and kidney transplantation, but few scholars concerned about CKD and cardiovascular disease (CVD) relationship. Now that CKD with CVD-related, and progress than acute renal failure more likely die of cardiovascular disease, CVD is the most common CKD the cause of death [1]. Recognized that CKD is a risk factor for CVD that is very important. Only in this way will it be possible to conduct an in-depth, and then search for the prevention and treatment of related measures to ensure greater benefits for these patients.
CKD is defined as biopsy or the markers of renal damage confirmed> 3 months, or GFR <60ml / (min.1.73m2)> 3 months. Cause of disease and the general based on credits for the diabetic and non-diabetic renal disease and transplantation. Renal dysfunction by renal biopsy or related markers such as proteinuria, abnormal urinary sediment, abnormal imaging to diagnose and so on. Proteinuria is not only to prove the existence of CKD, renal disease may also become an important basis for the type of diagnosis and the severity of kidney disease and cardiovascular disease-related. Urinary albumin and creatinine ratio or total protein and creatinine ratio can be used to assess proteinuria. GFR <60ml / (min.1.73m2) renal damage as a critical value, which indicates the level of GFR is often the beginning of renal failure, including increased incidence of cardiovascular disease and the degree of risk. GFR <15ml / (min.1.73m2) will need dialysis treatment.

GKD especially terminal kidney disease (ESRD) patients, CVD risk of a marked increase in general through the vascular tree to achieve. ESRD with atherosclerosis may be a causal relationship to each other, on the one hand, accelerated atherosclerosis in kidney disease progress, on the other hand, ESRD is the deterioration of many of the traditional atherosclerotic risk factors [2]. In general, CVD is the basic types of vascular disease and cardiomyopathy, the two subtypes of vascular disease is atherosclerosis and vascular remodeling, and CKD are the role of these two subtypes. Atherosclerotic plaque formation and the main obstruction in the main, CKD in atherosclerosis and the high incidence of a much wider range of diffuse atherosclerosis in a marked increase in cardiovascular disease mortality and accelerated deterioration of renal function. Atherosclerosis can lead to arterial wall thickening and myocardial ischemia matrix. In CKD patients, ischemic heart disease such as angina, myocardial infarction and sudden death, and cerebrovascular disease, peripheral vascular disease and heart failure are more common. Initially that the dialysis patients may be secondary to ischemic heart disease in easy to overload, left ventricular hypertrophy and small artery disease, resulting in reduced oxygen supply. However, studies have found that EPO in the former region, the low level of hemoglobin that also may be associated with ischemia-related. CKD patients the incidence of major vascular remodeling is higher, can lead to vascular remodeling in pressure overload, through the wall and the cavity wall thickening and increased the ratio of traffic overload, or to achieve, but mainly to increase the diameter and the wall thickness of main. Vascular remodeling in arterial compliance often dropped, resulting in increased systolic blood pressure, pulse pressure increased, left ventricular hypertrophy and reduced coronary perfusion [3,4]. Decreased arterial compliance and increased pulse pressure in dialysis patients are cardiovascular disease (CVD) risk factors independent [5].水钠潴留period as a result of dialysis treatment by ultrafiltration, dialysis patients with the diagnosis of heart failure more difficult, but the decline in blood pressure, fatigue, loss of appetite and other signs of heart failure diagnosis can be used as an important clue; On the other hand, more水钠潴留inappropriate to reflect the ultrafiltration rather than heart failure or heart failure combined ultrafiltration inappropriate. In fact, during dialysis ultrafiltration is inappropriate for one of the reasons why high blood pressure, heart failure often prompts. Therefore, dialysis patients with heart failure is an important indicator of poor prognosis, which often prompts the patient is in progress of cardiovascular disease.

1 chronic kidney disease risk factors of cardiovascular disease

Is well known that patients suffering from kidney disease increase in cardiovascular disease mortality, largely attributable to high blood pressure caused by kidney disease, dyslipidemia, and anemia, but may lead to the causes of plaque rupture is not clear. Light to moderate CKD patients significantly increased the risk of vascular events, and when GFR <45ml / (min.1.73m2) at the risk greater. Recent studies suggest that due to ACEI (such as captopril, etc.) can reduce chronic kidney disease patients after myocardial infarction risk, if there is no clear contraindication, it is recommended conventional [6]. In normal circumstances, the application of chronic kidney disease treatment of ACEI or ARBs should be careful, it is necessary to understand the benefits of the application, but also take into account blood pressure, renal function, blood electrolyte changes, and possible interactions between drugs, such as the decline in renal function occur, increased serum potassium, etc. must be stopped [1].

In CKD in CVD risk factors to be divided into two types of traditional and non-traditional, traditional risk factors are the main means used to assess symptoms of ischemic heart disease factors such as age, diabetes, systolic blood pressure, left ventricular hypertrophy, and low HDL - C and so on, these factors and the relationship between cardiovascular disease and most people are the same.

And define the non-traditional risk factors need to meet the following conditions: (1) to promote the development of CVD rationality biology; (2) the risk factors increased with the severity of kidney disease-related evidence; (3) reveals the CKD and the risk of CVD factors relevant evidence; (4) risk factors in the control group after treatment to reduce CVD evidence. Has been identified in non-traditional risk factors are mainly Hyperhomocysteinemia, oxidative stress, abnormal lipid levels, and atherosclerosis-related increase in markers of inflammation [7]. Recent study found that dialysis patients with oxidative stress and inflammatory markers significantly higher than the general population. Oxidative stress and inflammation may become the basic medium, while other factors such as anemia and cardiac disease, and calcium and phosphorus metabolic abnormalities and vascular remodeling and a decline in vascular compliance.

1.1 Failure cardiovascular disease

CVD mortality in dialysis patients than the general population 10 to 30 times, and the emergence of heart failure after acute myocardial infarction and high mortality rates, myocardial infarction within 1 to 2 years up to 59% mortality ~ 73%, significantly higher than the general crowd, and the Worcester heart Attack Study found that 3 / 4 males and 2 / 3 of women suffering from acute myocardial infarction in diabetic patients still alive after 2 years. At the same time hemodialysis patients atherosclerosis, heart failure and left ventricular hypertrophy abnormally high incidence of nearly 40% of the patients of ischemic heart disease or heart failure.

1.2 Cardiovascular disease after renal transplantation

Renal transplant patients, 35% ~ 50% of CVD death, CVD mortality than the general population of high 2-fold, but was significantly lower than that in hemodialysis patients. The most likely reason is acceptable from a kidney transplant and dialysis-related hemodynamic abnormalities and abnormal toxins. CVD after renal transplantation is the multiple risk factors, and not only include traditional factors such as hypertension, diabetes, hyperlipidemia, left ventricular hypertrophy, and have a decline in GFR of the non-traditional factors such as hyperhomocysteinemia, as well as immune suppression and exclusion.

1.3 of cardiovascular disease in diabetic nephropathy

Early diabetic nephropathy is mainly expressed in microalbuminuria, and progression of cardiovascular disease. Although type 1 diabetes patients with normal blood pressure, but was found in 24h at night to monitor the existence of "Nondipping" mode, may lead to microalbuminuria. "Nondipping" is identified the risk factors of cardiovascular disease, microalbuminuria with the diabetic patients are more vulnerable to dyslipidemia, blood glucose and blood pressure difficult to control. The study has confirmed that microalbuminuria with CVD have a clear relationship between the two types of diabetes in both the presence, but because of the age factor in type 2 diabetes in the more significant. Microalbuminuria is now considered that the prognosis of diabetic patients with cardiovascular disease and other factors in the risk of death indicators point of view can be explained as follows: (1) traditional microalbuminuria individual a higher incidence of risk factors; (2) micro - proteinuria can reflect the endothelial dysfunction, increased vascular permeability, abnormal coagulation and fibrinolysis system; (3) and inflammatory markers related; (4) are more vulnerable to end-organ damage. Prior studies suggest that the recent high blood pressure and vascular endothelial dysfunction, and therefore these patients may further aggravate the endothelial damage. However, the mechanism is not entirely clear at present that may be related to L-arginine transport by endothelial cells to damage, which led to the cell matrix of the lack of NO synthesis.

1.4 Non-diabetic renal disease cardiovascular disease

We mainly albuminuria and decreased GFR as a sign of chronic kidney disease, proteinuria than at the same time that microalbuminuria is more important, because whether or not there is diabetes, nephrotic syndrome and cardiovascular disease are related to the existence of the abnormal changes, such as serious hyperlipidemia and high blood coagulation status, etc. This explains the importance of reducing proteinuria. At present, we risk groups were divided into 3 groups, has been suffering from CVD, other vascular disease or diabetes as a high-risk groups; with traditional CVD risk factors such as high blood pressure, age, etc., as the crowd in danger; the community known as the low-risk group members

翻译.. 慢性肾病是心血管疾病的危险因素

慢性肾病（CKD）是值得广泛关注的公共健康，发病率逐渐上升，同时带来了严重的后果和问题。我们注意到肾衰病人的主要是透析和肾移植，但是很少有学者关注CKD与心血管疾病（CVD）的关系。现已认为CKD也与CVD有关，且比急性进展中的肾功能衰竭更容易死于心血管疾病，CVD是 CKD最常见的死亡原因〔1〕。认识到CKD是CVD的高危因素这一点，是很重要的。只有这样，才有可能进行深入，进而寻求相关的预防和治疗措施，使这些病人获得更大益处。
CKD是指由肾活检或有关的标志物证实的肾功损害＞3个月，或GFR＜60ml/（min.1.73m2）＞3个月。一般依据病和病因学分为糖尿病性、非糖尿病性和移植后肾病。肾功能损害可通过肾活检或相关的标志物如蛋白尿、异常尿沉积物、影像学异常等来诊断。蛋白尿不仅可以证明CKD的存在，亦可成为肾病类型诊断的重要依据，并与肾脏疾病的严重程度和心血管疾病的有关。尿白蛋白与肌酐比率或总蛋白与肌酐比率可用于评估蛋白尿。GFR＜60ml/（min.1.73m2）作为肾功损害的临界值，该水平GFR往往预示肾衰的开始，其中也包括增加心血管疾病的发生及危险程度。GFR＜15ml/（min.1.73m2）则需要透析治疗。

GKD尤其是终末肾病（ESRD）患者，CVD危险明显增加，一般通过血管树来实现的。ESRD与动脉粥样硬化可能互为因果关系，一方面粥样硬化加速肾病进展，另一方面ESRD恶化是许多传统粥样硬化的危险因素〔2〕。一般而言，CVD的基本类型是血管疾病和心肌病，血管疾病的两种亚型是动脉粥样硬化和大血管重塑，而CKD对这两种亚型均有作用。动脉粥样硬化主要以斑块形成和闭塞为主，CKD中动脉粥样硬化发生率很高而且范围更广，弥漫的粥样硬化明显增加心血管疾病死亡率和加速肾功能恶化。动脉粥样硬化可导致动脉壁基质增厚和心肌缺血。在CKD病人中，缺血性心脏病如心绞痛、心梗和猝死，以及脑血管疾病、外周血管疾病和心衰都是比较常见的。最初认为透析病人出现缺血性心脏病可能继发于容易超载、左室肥厚和小动脉病变，导致氧供减少。但是后来的研究发现，在前促红素区域，血红蛋白水平低，说明亦可能与缺血有关。CKD病人大血管重塑发生率亦较高，血管重塑可导致压力超载，通过管壁增厚和管壁与内腔比值增高或者流量超载来实现，但主要以增加的管壁直径和厚度为主。血管重塑常常使动脉顺应性下降，导致收缩压增加、脉压增大、左室肥厚和冠脉灌注减少〔3，4〕。动脉顺应性下降和脉压增大均为透析病人心血管疾病（CVD）的独立危险因素〔5〕。由于透析期间水钠潴留可通过超滤得到治疗，透析病人心衰的诊断比较困难，但血压下降、疲劳、食欲减退等征象，可作为心衰诊断的重要线索；另一方面，水钠潴留更能反映超滤不合适，而不是心衰或心衰合并超滤不恰当。实际上，透析期间超滤不合适的原因之一就是高血压，往往提示心衰。因此，心衰是透析病人预后不良的重要指标，这往往提示病人心血管疾病正在进展。

1 慢性肾病的心血管疾病危险因素

众所周知，患肾脏疾病的病人心血管病死亡率增加，很大程度上归因于肾病所致的高血压、血脂异常和贫血，但可能导致粥样斑块破裂的原因还不是很清楚。轻到中度CKD病人血管事件危险明显增高，而当GFR＜45ml/（min.1.73m2）时这种危险更大。近期有关研究认为因 ACEI（如卡托普利等）可降低慢性肾病病人心梗后的危险，如没有明显禁忌证，建议常规〔6〕。而在一般情况下，慢性肾病应用ACEI或ARBs治疗要慎重，既要了解应用的益处，又要考虑到血压、肾功能、血电解质变化和可能的药物间相互作用，如出现肾功能下降、血钾增高等就必须停药〔1〕。

在CKD中把CVD的危险因素分为传统和非传统两种，传统的危险因素主要指用于评估有症状缺血性心脏病的因素，如年龄、糖尿病、收缩性高血压、左室肥厚、低HDL-C等，这些因素与心血管疾病的关系与一般人是一致的。

而界定非传统危险因素需要满足如下条件：（1）促进CVD发展的生物学方面的合理性；（2）危险因素升高与肾病严重程度相关的证据；（3）揭示CKD中CVD与危险因素关系的相关证据；（4）有对照组中危险因素经治疗后CVD降低的证据。目前已确定的非传统危险因素主要有高同型半胱氨酸血症、氧化应激、异常脂血症、与粥样硬化有关的增高的炎症标志物〔7〕。近来研究发现，透析病人氧化应激和炎症标志物水平明显高于一般人群。氧化应激和炎症有可能成为基本的介质，而其他因素如贫血与心肌病有关，钙磷代谢异常与血管重塑和血管顺应性下降有关。

1.1 肾衰中心血管疾病

透析病人中CVD死亡率比普通人群高10～30倍，而出现急性心梗和心衰后致死率很高，心梗后1～2年死亡率达59%～73%，明显高于一般人群，而Worcester heart Attack研究发现，有3/4男性和2/3女性糖尿病病人患急性心梗后仍存活2年以上。同时血液透析病人动脉粥样硬化、心衰和左室肥厚发生率异常增高，有接近40%的病人出现缺血性心脏病或心衰。

1.2 肾移植后心血管疾病

肾移植病人中有35%～50%因CVD死亡，CVD死亡率比普通人群高2倍，但明显低于血液透析病人。最可能的原因是接受肾移植后免除了与透析有关的血流动力学异常和毒素异常。肾移植后CVD的危险因素是多重的，既包括传统因素如高血压、糖尿病、高脂血症、左室肥厚，亦有与GFR 下降有关的非传统因素如高同型半胱氨酸血症以及免疫抑制和排斥。

1.3 糖尿病肾病的心血管疾病

糖尿病肾病的早期主要表现为微量白蛋白尿，与心血管疾病进展有关。尽管1型糖尿病病人血压正常，但在24h监测中发现夜间存在 “Nondipping”模式，可能导致微量白蛋白尿。“Nondipping”是已确认的心血管疾病的危险因素，伴有微量白蛋白尿的糖尿病病人也更易出现血脂异常、血糖难以控制和血压升高。有关研究已证实微量白蛋白尿与CVD有明确关系，在两种类型糖尿病中均存在，但由于年龄因素在2型糖尿病中更显著。现已认为微量白蛋白尿是糖尿病病人心血管疾病预后和其他致死因素的危险指标，可通过如下观点来解释：（1）微量白蛋白尿个体传统危险因素发生率更高；（2）微量白蛋白尿能反映内皮功能异常、血管渗透性增加、凝血纤溶系统异常；（3）与炎症标志物有关；（4）更易出现终末器官损害。最近Prior研究认为高血压与血管内皮功能异常有关，因此在这类病人中可能进一步加重内皮损害。但有关机制不完全清楚，目前认为可能与L-精氨酸转运至内皮细胞受到损害有关，进而导致细胞内合成NO的基质缺乏。

1.4 非糖尿病性肾病的心血管疾病

我们主要把蛋白尿和GFR下降作为慢性肾病的标志，同时认为蛋白尿比微量白蛋白尿更重要，因为无论是否存在糖尿病，肾病综合征均存在与心血管疾病有关的异常改变，如严重高脂血症和高凝血状态等，这就说明降低蛋白尿具有重要意义。目前我们把危险人群分为3组，已经患CVD、其他血管病或糖尿病作为高危人群；具有CVD传统的易患因素如高血压、年龄等作为中危人群；将社区人员称为低危人群

医学论文翻译有什么好的方法吗？

据学术堂了解，在医学论文的翻译过程中，不少医学工作者表示中医术语翻译好难。翻译中医术语，不仅需要具备翻译功底，还须熟知中医学理论和扎实的古汉语知识。所以，难是可以理解的。为了帮助医学工作者解决烦恼，下面我们来谈谈医学术语的翻译方法。
一、科技英语常用构词法。
在科技英语构词中，普遍运用的是复合法、缀合法、缩合法、首字母缩略等，这些方法在中医术语翻译时均可借鉴。
1、复合法这类术语在中医术语翻译中占了很大的比例，其含义大多是各个词含义的叠加。采用这种译法的优点是容易找到对应词，结构明了，易于理解。缺点是译文往往不够简洁。
2、缀合法此类术语的含义为词缀与词干意义的相加，特点是简洁，专业性强，与西医术语的可比性强，便于学术交流。但在目前中医术语翻译中，这类词的使用比例并不高，如针灸。
3、缩合法其含义通常是构成该词的两个部分的词语意义相加，其特点类似缀合法。例如针压。
4、首字母缩略这种方法在科技英语(包括医学英语)中使用得非常广泛，但在中医英语中却很少使用。目前被普遍接受的只有”中医”一词。当然，也有学者在这方面做了有益的尝试，如将温病缩略为。首字母缩略是一种非常便捷的构词方式，可提高单位词汇的信息量。但是，如何运用这一方法使中医术语趋于简洁，规范，还有待进行深入的研究。
二、其他翻译方法
1、词性的转换由于中文和英文的语言结构，表达方式不同，在翻译时要将中医术语的结构进行转换。较常用的方法是将中文的主谓结构，动宾结构转换成英文中的名词性词组或非限定动词词组。例如 止痛等。对症状的描述也多采用类似的方法。由于症状表示的是一种状态，而非具体动作，其中文可采用主谓或动宾等词组来描述，而在英语中则常采用名词(词组)或动名词(词组)的形式。如盗汗等。
2、结构调整中医术语大多形成于中国古代，故语言形式上保留了古汉语的特点，讲究工整对仗。但在译成英语时，往往需要对这类结构进行调整，采用符合目的语语言习惯的结构，实现意义上的忠实。如神疲肢倦，心悸怔忡等。
3、音译法由于东西方文化和中西医理论之间存在很大的差异，所以有不少中医术语很难在西医(英语)中找到对应的词，用意译的方法则译文过于冗长，不符合术语简洁精练的要求。在这种情况下，采用音译不失为一种可取的选择，必要时可加以注释，以弥补音译的不足。例气一，气功一，阴阳一。气是中医理论中的一个重要概念，它既可以指人体的生命物质，也可以指人体的生理功能。用音译法来翻译，则最直接，最简洁地反映出了”气”的真实内涵。

基本上，医学工作者翻译医学术语，可以从以上两种方法出发。当然，在翻译的过程中也要注意实际的语境要求。最后，希望这两种翻译方法可以帮助到大家。

医学论文如何正确翻译专业术语

医学论文翻译一般较多的是医学论文的摘要翻译，即把医学论文的摘要翻译成英文，在国外期刊上发表都会要求整篇论文翻译成英文。
一、在相关专业医学论文翻译中，要达到表意准确，必须了解相关领域的知识，熟练掌握同一概念的中英文表达法。
单纯靠对语言的把握也能传达双方的语言信息，但在运用语言的灵活性和准确性两方而部会受到很大限制。要解决这个问题，译者就要努力熟悉这个领域的相关知识，比如，因此了解相关领域知识，在翻译过程中对翻译人员的语言理解力和医学论文翻译质量都有很大帮助。
二、医学论文翻译的翻译标准。
医学论文翻译标准是翻译实践的准绳和衡量译文好坏的尺度。关于翻译的标准，历来提法很多。有的主张“信、达、雅”，有的主张“信、顺”等等。但有一点是共同的，即一切译文都应包括原文思想内容和译文语言形式这两方面。
>为此，在进行医学论文翻译时应坚持两条标准：
>（一）忠实。应忠实于原内容，准确地、完整地、科学地表达原文的内容不得有任何篡改、歪曲、遗漏或任意增删的现象。内容通常指文中所叙述的事实，说明的事理，作者在叙述、说明和描写过程中所反映的思想、观点、立场和所流露的感情等。
>（二）通顺。医学论文翻译语言必须通顺易懂，符合规范，用词造句应符合本族语的习惯，要用民族的、科学的、大众的语言，以求通顺易懂。不应有文理不通、结构混乱、逐词死译和生硬晦涩等现象。
三、过程中要体现语言结构特色
（一）词汇上的特点
1. 词义演变。医学论文翻译的专业词汇通常都出现在特定领域，它一般分为两类：一类是某一专业特有的词汇，这类词汇一般具有一词对应一义的特点；还有一类由普通词汇演变而来的专业词汇，这类词汇一词多义，必须应用语言学知识和专业知识综合分析，在翻译实践中不断丰富扩大。
2. 词缀。比如：从词源学的角度来看，在医学英语词汇中，希腊语、拉丁语的词素占有极高比率。据Oscar n的统计，一万个医学词汇约有46%来自拉丁语；7.2%来自希腊语，希腊、拉丁词素是医学英语词汇的重要基础。希腊语、拉丁语拥有极丰富的词缀，且每个词缀都有其固定意义，可与不同的词干组成无数新词。
3. 动词多使用规范的书面语。英语词汇从语体的特点来分，可分为普通词汇和正式词汇。普通词汇大部分是英语本族语，常用于英语口语和文学作品中，正式词汇大部分是外来词，常用于科技、经济、政治等较正式的文章中。
（二）大量使用名词化结构
1. 医学论文中大量使用名词化结构 (Nominalization)是医学论文翻译的特点之一，因为文体要求行文简洁、表达客观、内容确切、信息量大、强调存在的事实，而非某一行为。
2. 大量使用长句和定语从句
医学论文翻译中大量使用长句和定语从句，在论证上起到连接信息和强调信息的作用。
3. 名词作定语和缩写词使用频繁。医学论文翻译中要求行文简炼、结构紧凑，名词作定语和缩写词的频繁使用，简化了句型，增大了信息密度。
4. 广泛使用被动语态。医学论文中侧重叙事推理，强调客观准确，第一、二人称使用过多，会造成主观臆断的印象。因此尽量使用第三人称叙述，采用被动语态。
四、医学论义翻译的翻译方法。
医学论义翻译要提高翻译量，使译文达到准确、通顺这两个标准，就必须运用医学论文翻译技巧。医学论文翻译技巧指翻译过程中用词造句的处理方法，如词义的引申、增减、词类转换和领域术语的翻译方法等。
（一）引申法。医学论文翻译时，有时会遇到某些词在英语词典上找不到适当的词义，如果任意硬套或逐词死译，会使医学论文翻译生硬晦涩，不能确切表达原意，甚至造成误解。这时则可以在不脱离该英语词义的前提下，灵活选择怡当的汉语词语或词组译出。
（二）增词译。由于英汉两种语言在词语用法、句子结构和表达方式上有许多差异，医学论文翻译时往往需要增加一些原文中没有的词，使译文通顺而且更加忠实地表达原文的意思。增词译的情况有两种。一种是根据意义或修辞的需要，如增加表示时态意义的词，增加英语不及物动词隐含的宾语意义的词。另一种是根据句法上的需要，增加原文句子中所省略的词。
（三）省略译。省略译是将原文中的宥些词省略不译，以使译文符合语言习惯。
（四）词类转换英译汉时，常常需要将英语句子中属于某种词类的词，译成另一种词类的汉语词，以使译文通顺自然，符合汉语的表达习惯。这种翻译处理方法就是转换词性法，简称词类转换。
（五）领域专业术语的译法。医学论文翻译中有大量的术语，而且科学性、专业性很强。领域专业术语的译法有意译、音译、象形译和原形译四种。
总之，医学论文的翻译需要专业的医学学科知识和大量对学术名词的积累。
希望能帮到你，也可以自己去找相关的机构帮你